M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

124 deals · US$156bndisclosed · Biotech · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced2,400.0Biotech+1 Lazard (sell-side)Goodwin (sell-side)Paul, Weiss (buy-side)
Feb 2026 PrimeGen US –DT Cloud Star AcquisitionMergerAnnounced1,500.0Biotech+1 A.G.P./Alliance Global Partners (sell-side)Sichenzia Ross Ference Carmel (sell-side)Loeb & Loeb (buy-side)
Jan 2026 Repare Therapeutics –XenoTherapeuticsAcquisitionCompleted–Biotech+1 Cooley (sell-side)Stikeman Elliott (sell-side)
Jan 2026 AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 AbelZetaAstraZenecaAsset saleAnnounced630.0Biotech+2 Davis Polk (sell-side)
Jan 2026 RAPT Therapeutics –GSKAcquisitionAnnounced2,200.0Biotech+1 J.P. Morgan (sell-side)Cooley (sell-side)Latham & Watkins (sell-side)Evercore (buy-side)A&O Shearman (buy-side)
Jan 2026 SL Bio –Horizon Space Acquisition II Corp.MergerAnnounced5,568.0Biotech VCL Law (sell-side)Ogier (sell-side)King Kee Appraisal and Advisory (buy-side)Robinson & Cole (buy-side)Maples Group (buy-side)
Jan 2026 InduPro Therapeutics –Eli Lilly and CompanyStakeAnnounced–Biotech+2 Freshfields (buy-side)
Jan 2026 Ventyx Biosciences –Eli Lilly and CompanyAcquisitionAnnounced1,200.0Biotech+2 Jefferies (sell-side)Moelis & Company (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Ropes & Gray (buy-side)
Jan 2026 Dark Blue Therapeutics –AmgenAcquisitionCompleted840.0Biotech+2 Goodwin (sell-side)BofA Securities (sell-side)
Jan 2026 Mersana Therapeutics –Day One BiopharmaceuticalsAcquisitionCompleted–Biotech+2 TD Securities (sell-side)WilmerHale (sell-side)Gordon Dyal & Co. (buy-side)Fenwick & West (buy-side)
2026 Calytrix Bio –Eli LillyAcquisitionAnnounced1,500.0Biotech Centerview Partners (sell-side)
2026 AttaiBeckley –Eli Lilly and CompanyAcquisitionAnnounced3,800.0Biotech+2 Moelis & Company (sell-side)
2026 FireFly Biologics –J&JAcquisitionAnnounced1,000.0Biotech+1 Centerview Partners (sell-side)
Dec 2025 Dynavax Technologies –SanofiAcquisitionAnnounced2,200.0Biotech+1 Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side)
Dec 2025 Amicus Therapeutics –BioMarinAcquisitionAnnounced4,800.0Biotech+2 Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 MindWave Innovations –Apimeds Pharmaceuticals USMergerCompleted–Biotech+1 Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side)
Nov 2025 Aptose Biosciences –HS North AmericaAcquisitionAnnounced–Biotech+2 Locust Walk (sell-side)Stikeman Elliott (buy-side)
Oct 2025 Avidity Biosciences –NovartisAcquisitionAnnounced11,000.0Biotech+2 Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side)
Oct 2025 Astria Therapeutics –BioCryst PharmaceuticalsAcquisitionCompleted700.0Biotech+2 Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Feb 2025 Instinct Bio Technical Company –Relativity Acquisition SponsorMergerPending225.0Biotech Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side)
– Barinthus Biotherapeutics ––MergerAnnounced–Biotech Oppenheimer & Co. (sell-side)Snell & Wilmer (sell-side)D. Boral Capital (buy-side)
– Telomir Pharmaceuticals ––MergerAnnounced47.1Biotech+1

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.